CSL Limited (ASX:CSL)
Australia · Delayed Price · Currency is AUD 177.15
-2.16 (-1.20%)
At close: Dec 16, 2025
CSL Limited Market Cap
CSL Limited has a market cap or net worth of 85.46 billion as of December 16, 2025. Its market cap has decreased by -37.99% in one year.
Market Cap
85.46B
Enterprise Value
102.86B
Revenue
23.73B
Ranking
n/a
PE Ratio
18.82
Stock Price
177.15
Market Cap Chart
Since June 2, 1994, CSL Limited's market cap has increased from 312.00M to 85.46B, an increase of 27,289.79%. That is a compound annual growth rate of 19.46%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 15, 2025 | 86.50B | -36.56% |
| Dec 31, 2024 | 136.34B | -1.54% |
| Dec 29, 2023 | 138.48B | -0.20% |
| Dec 30, 2022 | 138.76B | -0.30% |
| Dec 31, 2021 | 139.18B | 8.03% |
| Dec 31, 2020 | 128.84B | 2.94% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Pro Medicus | 24.49B |
| Cochlear | 17.23B |
| Sonic Healthcare | 11.46B |
| Ramsay Health Care | 8.16B |
| Ansell | 5.12B |
| Telix Pharmaceuticals | 4.65B |
| Mesoblast | 3.55B |
| Neuren Pharmaceuticals | 2.41B |